CD56bright natural killer (NK) cells: an important NK cell subset

Human natural killer (NK) cells can be subdivided into different populations based on the relative expression of the surface markers CD16 and CD56. The two major subsets are CD56bright CD16dim/− and CD56dim CD16+, respectively. In this review, we will focus on the CD56bright NK cell subset. These cells are numerically in the minority in peripheral blood but constitute the majority of NK cells in secondary lymphoid tissues. They are abundant cytokine producers but are only weakly cytotoxic before activation. Recent data suggest that under certain conditions, they have immunoregulatory properties, and that they are probably immediate precursors of CD56dim NK cells. CD56bright NK cell percentages are expanded or reduced in a certain number of diseases, but the significance of these variations is not yet clear.

[1]  G. Trinchieri,et al.  Human natural killer cells. , 1979, Transplantation proceedings.

[2]  L. Lanier,et al.  Comparative studies of human FcRIII-positive and negative natural killer cells. , 1989, Journal of immunology.

[3]  K. Solomon,et al.  Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells). , 1995, Cellular immunology.

[4]  M. Wilders-Truschnig,et al.  Differential phenotypic properties of human peripheral blood CD56dim+ and CD56bright+ natural killer cell subpopulations. , 1996, International archives of allergy and immunology.

[5]  Caligiuri,et al.  Natural Killer Cell Subsets and Development , 1996, Methods.

[6]  L. Moretta,et al.  NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis , 1998, The Journal of experimental medicine.

[7]  G. Freeman,et al.  Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. , 1998, Journal of immunology.

[8]  L. Lanier.  NK cell receptors. , 1998, Annual review of immunology.

[9]  M. Caligiuri,et al.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. , 1999, Journal of immunology.

[10]  P. Anderson,et al.  Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[12]  R. Jacobs,et al.  CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells , 2001, European journal of immunology.

[13]  James J. Campbell,et al.  Unique Subpopulations of CD56+ NK and NK-T Peripheral Blood Lymphocytes Identified by Chemokine Receptor Expression Repertoire1 , 2001, The Journal of Immunology.

[14]  J. Zimmer,et al.  Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. , 2002, Blood.

[15]  M. Caligiuri,et al.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. , 2003, Blood.

[16]  R. Moots,et al.  Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype. , 2003, Rheumatology.

[17]  R. Moots,et al.  Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD 56 bright , CD 94 bright , CD 158 negative phenotype , 2003 .

[18]  P. Park,et al.  Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential , 2003, The Journal of experimental medicine.

[19]  Dolca Thomas,et al.  The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic1 , 2004, The Journal of Immunology.

[20]  A. Thiel,et al.  The small subset of CD56brightCD16– natural killer cells is selectively responsible for both cell proliferation and interferon‐γ production upon interaction with dendritic cells , 2004, European journal of immunology.

[21]  R. Davies,et al.  CD56bright NK Cells Are Enriched at Inflammatory Sites and Can Engage with Monocytes in a Reciprocal Program of Activation1 , 2004, The Journal of Immunology.

[22]  J. Hanna,et al.  Novel Insights on Human NK Cells’ Immunological Modalities Revealed by Gene Expression Profiling1 , 2004, The Journal of Immunology.

[23]  C. Münz,et al.  NK Cell Compartments and Their Activation by Dendritic Cells1 , 2004, The Journal of Immunology.

[24]  N. Malats,et al.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. , 2004, Blood.

[25]  R. Nussenblatt,et al.  Cutting Edge: In Vivo Blockade of Human IL-2 Receptor Induces Expansion of CD56bright Regulatory NK Cells in Patients with Active Uveitis , 2005, The Journal of Immunology.

[26]  E. Giannini,et al.  Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome , 2004, Arthritis research & therapy.

[27]  J. Grunewald,et al.  Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients , 2005, European Respiratory Journal.

[28]  A. Fauci,et al.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Gazzard,et al.  Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy , 2005, AIDS.

[30]  S. Nutt,et al.  Functional subsets of mouse natural killer cells , 2006, Immunological reviews.

[31]  G. Girolomoni,et al.  CD56brightCD16– NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation , 2006, European journal of immunology.

[32]  Z. Ballas,et al.  Recalcitrant warts, associated with natural killer cell dysfunction, treated with systemic IFN-alpha. , 2006, The Journal of allergy and clinical immunology.

[33]  A case of HHV-6 associated acute necrotizing encephalopathy with increase of CD56bright NKcells , 2006, Scandinavian journal of infectious diseases.

[34]  B. Clotet,et al.  Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. , 2006, The Journal of infectious diseases.

[35]  T. Waldmann,et al.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Buer,et al.  Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells , 2006, Journal of leukocyte biology.

[37]  S. Kōzuma,et al.  Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. , 2006, Journal of reproductive immunology.

[38]  D. Keskin,et al.  TGFβ promotes conversion of CD16+ peripheral blood NK cells into CD16− NK cells with similarities to decidual NK cells , 2007, Proceedings of the National Academy of Sciences.

[39]  A. Thiel,et al.  CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1 , 2007, The Journal of Immunology.

[40]  P. Lansdorp,et al.  Telomere Length in Human Natural Killer Cell Subsets , 2007, Annals of the New York Academy of Sciences.

[41]  T. Wada,et al.  Skin infiltration of CD56bright CD16‐ natural killer cells in a case of X‐SCID with Omenn syndrome‐like manifestations , 2007, European journal of haematology.

[42]  S. Buyny,et al.  Interleukin‐21 differentially affects human natural killer cell subsets , 2007, Immunology.

[43]  C. Hsu,et al.  Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases. , 2007, Advances in immunology.

[44]  L. Airas,et al.  Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta , 2007, Neurological Sciences.

[45]  E. Andrès,et al.  Phenotypic Studies of Natural Killer Cell Subsets in Human Transporter Associated with Antigen Processing Deficiency , 2007, PloS one.

[46]  J. Myśliwska,et al.  NK cell compartment in patients with coronary heart disease , 2007, Immunity & Ageing.

[47]  T. Enver,et al.  CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts , 2007, The Journal of Immunology.

[48]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[49]  S. Buyny,et al.  New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. , 2008, Immunobiology.

[50]  A. Shiozaki,et al.  The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. , 2008, Journal of reproductive immunology.

[51]  B. N. Carvalho,et al.  Natural Killer Cell Subpopulations in Putative Resistant Individuals and Patients with Active Mycobacterium tuberculosis Infection , 2008, Scandinavian journal of immunology.

[52]  D. Doherty,et al.  Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure , 2008, Gut.

[53]  G. Canonica,et al.  Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. , 2008, The Journal of allergy and clinical immunology.

[54]  F. Hentges,et al.  HLA class I deficiency syndrome mimicking Wegener's granulomatosis. , 2008, Arthritis and rheumatism.

[55]  I. Gunnarsson,et al.  Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus , 2009, Immunology.